0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rabies Vaccine for Pets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13G14633
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rabies Vaccine for Pets Market Research Report 2023
BUY CHAPTERS

Global Rabies Vaccine for Pets Market Research Report 2025

Code: QYRE-Auto-13G14633
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rabies Vaccine for Pets Market

The global market for Rabies Vaccine for Pets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rabies vaccine refers to the vaccine used to prevent rabies. There are many effective and safe vaccines available. The rabies vaccine can be given either before or some time after exposure to the virus (such as a dog or bat bite).
North American market for Rabies Vaccine for Pets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rabies Vaccine for Pets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rabies Vaccine for Pets include Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Bavarian Nordic, Dyntec, Sanofi-Pasteur, Tianjin Ringpu Bio-Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine for Pets.
The Rabies Vaccine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rabies Vaccine for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rabies Vaccine for Pets Market Report

Report Metric Details
Report Name Rabies Vaccine for Pets Market
Segment by Type
Segment by Application
  • Pet Hospital
  • Animal Epidemic Prevention Station
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Bavarian Nordic, Dyntec, Sanofi-Pasteur, Tianjin Ringpu Bio-Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rabies Vaccine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rabies Vaccine for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rabies Vaccine for Pets Market report?

Ans: The main players in the Rabies Vaccine for Pets Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Bavarian Nordic, Dyntec, Sanofi-Pasteur, Tianjin Ringpu Bio-Technology

What are the Application segmentation covered in the Rabies Vaccine for Pets Market report?

Ans: The Applications covered in the Rabies Vaccine for Pets Market report are Pet Hospital, Animal Epidemic Prevention Station

What are the Type segmentation covered in the Rabies Vaccine for Pets Market report?

Ans: The Types covered in the Rabies Vaccine for Pets Market report are Injectable Rabies Vaccine, Oral Rabies Vaccine

Recommended Reports

Rabies Market Reports

Veterinary Vaccines

Animal Disease Prevention

1 Rabies Vaccine for Pets Market Overview
1.1 Product Definition
1.2 Rabies Vaccine for Pets by Type
1.2.1 Global Rabies Vaccine for Pets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injectable Rabies Vaccine
1.2.3 Oral Rabies Vaccine
1.3 Rabies Vaccine for Pets by Application
1.3.1 Global Rabies Vaccine for Pets Market Value by Application (2024 VS 2031)
1.3.2 Pet Hospital
1.3.3 Animal Epidemic Prevention Station
1.4 Global Rabies Vaccine for Pets Market Size Estimates and Forecasts
1.4.1 Global Rabies Vaccine for Pets Revenue 2020-2031
1.4.2 Global Rabies Vaccine for Pets Sales 2020-2031
1.4.3 Global Rabies Vaccine for Pets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rabies Vaccine for Pets Market Competition by Manufacturers
2.1 Global Rabies Vaccine for Pets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rabies Vaccine for Pets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rabies Vaccine for Pets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rabies Vaccine for Pets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rabies Vaccine for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Vaccine for Pets, Product Type & Application
2.7 Global Key Manufacturers of Rabies Vaccine for Pets, Date of Enter into This Industry
2.8 Global Rabies Vaccine for Pets Market Competitive Situation and Trends
2.8.1 Global Rabies Vaccine for Pets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rabies Vaccine for Pets Players Market Share by Revenue
2.8.3 Global Rabies Vaccine for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rabies Vaccine for Pets Market Scenario by Region
3.1 Global Rabies Vaccine for Pets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rabies Vaccine for Pets Sales by Region: 2020-2031
3.2.1 Global Rabies Vaccine for Pets Sales by Region: 2020-2025
3.2.2 Global Rabies Vaccine for Pets Sales by Region: 2026-2031
3.3 Global Rabies Vaccine for Pets Revenue by Region: 2020-2031
3.3.1 Global Rabies Vaccine for Pets Revenue by Region: 2020-2025
3.3.2 Global Rabies Vaccine for Pets Revenue by Region: 2026-2031
3.4 North America Rabies Vaccine for Pets Market Facts & Figures by Country
3.4.1 North America Rabies Vaccine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rabies Vaccine for Pets Sales by Country (2020-2031)
3.4.3 North America Rabies Vaccine for Pets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Vaccine for Pets Market Facts & Figures by Country
3.5.1 Europe Rabies Vaccine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rabies Vaccine for Pets Sales by Country (2020-2031)
3.5.3 Europe Rabies Vaccine for Pets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Vaccine for Pets Market Facts & Figures by Region
3.6.1 Asia Pacific Rabies Vaccine for Pets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rabies Vaccine for Pets Sales by Region (2020-2031)
3.6.3 Asia Pacific Rabies Vaccine for Pets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rabies Vaccine for Pets Market Facts & Figures by Country
3.7.1 Latin America Rabies Vaccine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rabies Vaccine for Pets Sales by Country (2020-2031)
3.7.3 Latin America Rabies Vaccine for Pets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Vaccine for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Vaccine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rabies Vaccine for Pets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rabies Vaccine for Pets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Vaccine for Pets Sales by Type (2020-2031)
4.1.1 Global Rabies Vaccine for Pets Sales by Type (2020-2025)
4.1.2 Global Rabies Vaccine for Pets Sales by Type (2026-2031)
4.1.3 Global Rabies Vaccine for Pets Sales Market Share by Type (2020-2031)
4.2 Global Rabies Vaccine for Pets Revenue by Type (2020-2031)
4.2.1 Global Rabies Vaccine for Pets Revenue by Type (2020-2025)
4.2.2 Global Rabies Vaccine for Pets Revenue by Type (2026-2031)
4.2.3 Global Rabies Vaccine for Pets Revenue Market Share by Type (2020-2031)
4.3 Global Rabies Vaccine for Pets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rabies Vaccine for Pets Sales by Application (2020-2031)
5.1.1 Global Rabies Vaccine for Pets Sales by Application (2020-2025)
5.1.2 Global Rabies Vaccine for Pets Sales by Application (2026-2031)
5.1.3 Global Rabies Vaccine for Pets Sales Market Share by Application (2020-2031)
5.2 Global Rabies Vaccine for Pets Revenue by Application (2020-2031)
5.2.1 Global Rabies Vaccine for Pets Revenue by Application (2020-2025)
5.2.2 Global Rabies Vaccine for Pets Revenue by Application (2026-2031)
5.2.3 Global Rabies Vaccine for Pets Revenue Market Share by Application (2020-2031)
5.3 Global Rabies Vaccine for Pets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Rabies Vaccine for Pets Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Rabies Vaccine for Pets Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Rabies Vaccine for Pets Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Rabies Vaccine for Pets Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Virbac Rabies Vaccine for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Company Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bavarian Nordic Rabies Vaccine for Pets Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Dyntec
6.7.1 Dyntec Company Information
6.7.2 Dyntec Description and Business Overview
6.7.3 Dyntec Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dyntec Rabies Vaccine for Pets Product Portfolio
6.7.5 Dyntec Recent Developments/Updates
6.8 Sanofi-Pasteur
6.8.1 Sanofi-Pasteur Company Information
6.8.2 Sanofi-Pasteur Description and Business Overview
6.8.3 Sanofi-Pasteur Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi-Pasteur Rabies Vaccine for Pets Product Portfolio
6.8.5 Sanofi-Pasteur Recent Developments/Updates
6.9 Tianjin Ringpu Bio-Technology
6.9.1 Tianjin Ringpu Bio-Technology Company Information
6.9.2 Tianjin Ringpu Bio-Technology Description and Business Overview
6.9.3 Tianjin Ringpu Bio-Technology Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Tianjin Ringpu Bio-Technology Rabies Vaccine for Pets Product Portfolio
6.9.5 Tianjin Ringpu Bio-Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Vaccine for Pets Industry Chain Analysis
7.2 Rabies Vaccine for Pets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Vaccine for Pets Production Mode & Process Analysis
7.4 Rabies Vaccine for Pets Sales and Marketing
7.4.1 Rabies Vaccine for Pets Sales Channels
7.4.2 Rabies Vaccine for Pets Distributors
7.5 Rabies Vaccine for Pets Customer Analysis
8 Rabies Vaccine for Pets Market Dynamics
8.1 Rabies Vaccine for Pets Industry Trends
8.2 Rabies Vaccine for Pets Market Drivers
8.3 Rabies Vaccine for Pets Market Challenges
8.4 Rabies Vaccine for Pets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Rabies Vaccine for Pets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rabies Vaccine for Pets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rabies Vaccine for Pets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rabies Vaccine for Pets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rabies Vaccine for Pets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rabies Vaccine for Pets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rabies Vaccine for Pets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rabies Vaccine for Pets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rabies Vaccine for Pets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rabies Vaccine for Pets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rabies Vaccine for Pets, Product Type & Application
 Table 12. Global Key Manufacturers of Rabies Vaccine for Pets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rabies Vaccine for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine for Pets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rabies Vaccine for Pets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rabies Vaccine for Pets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rabies Vaccine for Pets Sales Market Share by Region (2020-2025)
 Table 19. Global Rabies Vaccine for Pets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rabies Vaccine for Pets Sales Market Share by Region (2026-2031)
 Table 21. Global Rabies Vaccine for Pets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rabies Vaccine for Pets Revenue Market Share by Region (2020-2025)
 Table 23. Global Rabies Vaccine for Pets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rabies Vaccine for Pets Revenue Market Share by Region (2026-2031)
 Table 25. North America Rabies Vaccine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rabies Vaccine for Pets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rabies Vaccine for Pets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rabies Vaccine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rabies Vaccine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rabies Vaccine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rabies Vaccine for Pets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rabies Vaccine for Pets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rabies Vaccine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rabies Vaccine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rabies Vaccine for Pets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rabies Vaccine for Pets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rabies Vaccine for Pets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rabies Vaccine for Pets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rabies Vaccine for Pets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rabies Vaccine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rabies Vaccine for Pets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rabies Vaccine for Pets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rabies Vaccine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rabies Vaccine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rabies Vaccine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rabies Vaccine for Pets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rabies Vaccine for Pets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rabies Vaccine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rabies Vaccine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rabies Vaccine for Pets Sales (K Units) by Type (2020-2025)
 Table 51. Global Rabies Vaccine for Pets Sales (K Units) by Type (2026-2031)
 Table 52. Global Rabies Vaccine for Pets Sales Market Share by Type (2020-2025)
 Table 53. Global Rabies Vaccine for Pets Sales Market Share by Type (2026-2031)
 Table 54. Global Rabies Vaccine for Pets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rabies Vaccine for Pets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rabies Vaccine for Pets Revenue Market Share by Type (2020-2025)
 Table 57. Global Rabies Vaccine for Pets Revenue Market Share by Type (2026-2031)
 Table 58. Global Rabies Vaccine for Pets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Rabies Vaccine for Pets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Rabies Vaccine for Pets Sales (K Units) by Application (2020-2025)
 Table 61. Global Rabies Vaccine for Pets Sales (K Units) by Application (2026-2031)
 Table 62. Global Rabies Vaccine for Pets Sales Market Share by Application (2020-2025)
 Table 63. Global Rabies Vaccine for Pets Sales Market Share by Application (2026-2031)
 Table 64. Global Rabies Vaccine for Pets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rabies Vaccine for Pets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rabies Vaccine for Pets Revenue Market Share by Application (2020-2025)
 Table 67. Global Rabies Vaccine for Pets Revenue Market Share by Application (2026-2031)
 Table 68. Global Rabies Vaccine for Pets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Rabies Vaccine for Pets Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Rabies Vaccine for Pets Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zoetis Rabies Vaccine for Pets Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Rabies Vaccine for Pets Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Rabies Vaccine for Pets Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. Virbac Company Information
 Table 91. Virbac Description and Business Overview
 Table 92. Virbac Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Virbac Rabies Vaccine for Pets Product
 Table 94. Virbac Recent Developments/Updates
 Table 95. Bavarian Nordic Company Information
 Table 96. Bavarian Nordic Description and Business Overview
 Table 97. Bavarian Nordic Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bavarian Nordic Rabies Vaccine for Pets Product
 Table 99. Bavarian Nordic Recent Developments/Updates
 Table 100. Dyntec Company Information
 Table 101. Dyntec Description and Business Overview
 Table 102. Dyntec Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Dyntec Rabies Vaccine for Pets Product
 Table 104. Dyntec Recent Developments/Updates
 Table 105. Sanofi-Pasteur Company Information
 Table 106. Sanofi-Pasteur Description and Business Overview
 Table 107. Sanofi-Pasteur Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sanofi-Pasteur Rabies Vaccine for Pets Product
 Table 109. Sanofi-Pasteur Recent Developments/Updates
 Table 110. Tianjin Ringpu Bio-Technology Company Information
 Table 111. Tianjin Ringpu Bio-Technology Description and Business Overview
 Table 112. Tianjin Ringpu Bio-Technology Rabies Vaccine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Tianjin Ringpu Bio-Technology Rabies Vaccine for Pets Product
 Table 114. Tianjin Ringpu Bio-Technology Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Rabies Vaccine for Pets Distributors List
 Table 118. Rabies Vaccine for Pets Customers List
 Table 119. Rabies Vaccine for Pets Market Trends
 Table 120. Rabies Vaccine for Pets Market Drivers
 Table 121. Rabies Vaccine for Pets Market Challenges
 Table 122. Rabies Vaccine for Pets Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rabies Vaccine for Pets
 Figure 2. Global Rabies Vaccine for Pets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rabies Vaccine for Pets Market Share by Type: 2024 & 2031
 Figure 4. Injectable Rabies Vaccine Product Picture
 Figure 5. Oral Rabies Vaccine Product Picture
 Figure 6. Global Rabies Vaccine for Pets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Rabies Vaccine for Pets Market Share by Application: 2024 & 2031
 Figure 8. Pet Hospital
 Figure 9. Animal Epidemic Prevention Station
 Figure 10. Global Rabies Vaccine for Pets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Rabies Vaccine for Pets Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Rabies Vaccine for Pets Sales (2020-2031) & (K Units)
 Figure 13. Global Rabies Vaccine for Pets Average Price (US$/Unit) & (2020-2031)
 Figure 14. Rabies Vaccine for Pets Report Years Considered
 Figure 15. Rabies Vaccine for Pets Sales Share by Manufacturers in 2024
 Figure 16. Global Rabies Vaccine for Pets Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Rabies Vaccine for Pets Players: Market Share by Revenue in Rabies Vaccine for Pets in 2024
 Figure 18. Rabies Vaccine for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Rabies Vaccine for Pets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Rabies Vaccine for Pets Sales Market Share by Country (2020-2031)
 Figure 21. North America Rabies Vaccine for Pets Revenue Market Share by Country (2020-2031)
 Figure 22. United States Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Rabies Vaccine for Pets Sales Market Share by Country (2020-2031)
 Figure 25. Europe Rabies Vaccine for Pets Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Rabies Vaccine for Pets Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Rabies Vaccine for Pets Revenue Market Share by Region (2020-2031)
 Figure 33. China Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Rabies Vaccine for Pets Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Rabies Vaccine for Pets Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Rabies Vaccine for Pets Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Rabies Vaccine for Pets Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Rabies Vaccine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Rabies Vaccine for Pets by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Rabies Vaccine for Pets by Type (2020-2031)
 Figure 52. Global Rabies Vaccine for Pets Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Rabies Vaccine for Pets by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Rabies Vaccine for Pets by Application (2020-2031)
 Figure 55. Global Rabies Vaccine for Pets Price (US$/Unit) by Application (2020-2031)
 Figure 56. Rabies Vaccine for Pets Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String